Tempus One AI Clinical Assistant Expands EHR Integration
Tempus AI integrates its generative AI clinical assistant Tempus One into EHR systems to enhance treatment decisions in oncology and other specialties.
Tempus AI, Inc. (NASDAQ:TEM), a leader in AI-driven precision medicine, has announced the expansion of its generative AI clinical assistant, Tempus One, with direct integration into electronic health record (EHR) systems. This development aims to streamline clinical workflows and improve treatment decision-making, particularly in oncology.
Key Features of Tempus One
- EHR Integration: Tempus One can now query patient data directly from EHR systems, providing real-time insights.
- Custom Agents: Physicians can build custom AI agents to optimize workflows and enhance patient care.
- Oncology Focus: While designed for broad use, the tool is particularly impactful in oncology, where precision medicine is critical.
Why This Matters
Tempus One's integration into EHR systems represents a significant step forward in AI-enabled clinical support. By embedding AI at every stage of the care process, Tempus AI aims to reduce physician burnout and improve patient outcomes.
Company Background
Tempus AI is known for its large-scale EHR data and AI capabilities, which uniquely position it to deliver these advanced features. The company continues to democratize access to cutting-edge technology in healthcare.
For more information, visit Quantisnow.
© 2025 quantisnow.com
Democratizing insights since 2022
Related News
AWS extends Bedrock AgentCore Gateway to unify MCP servers for AI agents
AWS announces expanded Amazon Bedrock AgentCore Gateway support for MCP servers, enabling centralized management of AI agent tools across organizations.
CEOs Must Prioritize AI Investment Amid Rapid Change
Forward-thinking CEOs are focusing on AI investment, agile operations, and strategic growth to navigate disruption and lead competitively.
About the Author
Dr. Emily Wang
AI Product Strategy Expert
Former Google AI Product Manager with 10 years of experience in AI product development and strategy formulation. Led multiple successful AI products from 0 to 1 development process, now provides product strategy consulting for AI startups while writing AI product analysis articles for various tech media outlets.